Therapeutic Agent For Chronic Renal Failure

Patent No. EP2305653 (titled "Therapeutic Agent For Chronic Renal Failure") was filed by Toray Industries on Jul 23, 2009. The application was issued on Jun 24, 2015.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACTELION PHARMACEUTICALSDec 3, 2015TEIPEL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2305653

TORAY INDUSTRIES
Application Number
EP09800423A
Filing Date
Jul 23, 2009
Status
Opposition Rejected
Aug 18, 2017
Publication Date
Jun 24, 2015